NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing

NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...
EurekAlert!

Zebrafish study highlights contralateral eye’s key role in visual function recovery

Optic neuropathies including glaucoma, traumatic injury, ischemic damage, and optic neuritis, are the leading causes of irreversible blindness worldwide; however, effective treatments for optic nerve ...
Business Insider

NurExone Invited Presenter at Precision EV Forum in Cambridge, UK

TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing ...
BioSpace

NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model

TORONTO and HAIFA, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a ...
Medscape

AI-Powered Model Can Classify Types of Optic Nerve Damage

A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...
Hosted on MSN

NervGen Pharma’s NVG-291-R Shows Promising Preclinical Results in Nerve Repair

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. NervGen Pharma ( (TSE:NGEN)) has issued ...
Scientific American

How Scientists Finally Learned That Nerves Regrow

We’re celebrating 180 years of Scientific American. Explore our legacy of discovery and look ahead to the future. Billions of nerve cells send signals coursing through our bodies, serving as conduits ...